INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 216 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.57 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24,234 | +116.7% | 62,298 | +148.7% | 0.00% | +200.0% |
| Q2 2023 | $11,185 | -48.5% | 25,049 | -5.5% | 0.00% | -50.0% |
| Q1 2023 | $21,736 | -49.1% | 26,508 | -3.2% | 0.00% | -60.0% |
| Q4 2022 | $42,711 | -99.9% | 27,379 | -2.8% | 0.01% | -16.7% |
| Q3 2022 | $48,602,000 | -6.3% | 28,175 | -6.0% | 0.01% | 0.0% |
| Q2 2022 | $51,878,000 | +61659.5% | 29,987 | +28.3% | 0.01% | -25.0% |
| Q1 2022 | $84,000 | -32.8% | 23,374 | -6.6% | 0.01% | -11.1% |
| Q4 2021 | $125,000 | -32.1% | 25,030 | -2.6% | 0.01% | -35.7% |
| Q3 2021 | $184,000 | -25.8% | 25,686 | -4.1% | 0.01% | -22.2% |
| Q2 2021 | $248,000 | +22.8% | 26,778 | +23.1% | 0.02% | +12.5% |
| Q1 2021 | $202,000 | – | 21,746 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 200,000 | $998,000 | 0.36% |
| Green Alpha Advisors, LLC | 72,647 | $363,000 | 0.24% |
| Skaana Management L.P. | 227,851 | $1,137,000 | 0.18% |
| SEVEN EIGHT CAPITAL, LP | 196,351 | $980,000 | 0.18% |
| Defender Capital, LLC. | 103,038 | $514,000 | 0.16% |
| Skaana Management L.P. | 206,300 | $1,029,000 | 0.16% |
| WASATCH ADVISORS LP | 4,926,125 | $24,581,000 | 0.10% |
| Parametrica Management Ltd | 16,183 | $81,000 | 0.08% |
| Cedar Brook Financial Partners, LLC | 54,500 | $272,000 | 0.07% |
| Hennion & Walsh Asset Management, Inc. | 274,703 | $1,371,000 | 0.07% |